Prime Therapeutics welcomes Christine Bent as new chief operating officer
Bent will lead Prime’s efforts to create the PBM of the future, working with the nation’s leading Blues plans to put caregivers and patients in a position to optimize health through advances in pharmacy management
December 2, 2019
Bent comes to Prime after serving as senior vice president of operations at Allina Hospital and Clinics, one of Minnesota’s leading not-for-profit health care systems. While there, she was responsible for the operational leadership of Allina’s primary and specialty care services, integrated specialists and related sites of care, as well as 90 clinics and 10 clinical service lines representing 10,000 staff members. Prior to that, she held executive operational roles at Minnesota-based Minneapolis Heart Institute and Atrius Health in Massachusetts.
“We are extremely fortunate to have Christine join Prime at a time when our industry and health care in general are undergoing major transformation,” said Ken Paulus, president and CEO of Prime. “Her in-depth knowledge of the health care industry and more than 25 years’ experience overseeing complex health care operations make her a great fit for our organization. Most importantly, Chris brings the values, principles, warmth, and commitment to service that are core tenets of our work at Prime.”
Bent earned a Master of Healthcare Administration degree from the University of Minnesota. She currently serves on the board of the Women’s Health Leadership TRUST and was the past board chair for the Minnesota chapter of the American Heart Association.
October 14, 2021
In first of its kind study, Prime Therapeutics explores paroxysmal nocturnal hemoglobinuria (PNH) C5 inhibitor treatment rates
EAGAN, Minn. – Leading pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime) used its…
October 6, 2021
Prime Therapeutics launches new MedsYourWay™ offering, now giving Blue Plan members home delivery prescription option using Amazon Pharmacy
EAGAN, Minn. – Prime Therapeutics LLC, a leading pharmacy benefit manager, announces its…
September 29, 2021
Prime Therapeutics and Pear Therapeutics announce first comprehensive value-based agreement for prescription digital therapeutics reSET® and reSET-O® for the treatment of substance and opioid use disorders
BOSTON and EAGAN, Minn. – More than 20 million Americans struggle with drug…